加载中...
2024-07-11
Greetings from Medalb Asia 2024! Lifotronic Technology has once again captivated the global healthcare community with its groundbreaking advancements in medical technology. This year's exhibition featured a diverse array of innovations across key product series: ECLIA, HPLC, CBC, and POCT, underscoring Lifotronic's commitment to pushing the boundaries of diagnostic excellence.
HPLC Series: Enhanced Diabetes Management
Lifotronic's HPLC series, highlighted by the flagship H100 HPLC Analyzer, redefines efficiency in diabetes management. With an impressive testing speed of 96 seconds per sample, the H100 combines speed with accuracy, facilitating seamless mode switching between Variant Mode and Thalassemia Mode. This capability ensures more precise diagnostic results for both diabetes and thalassemia patients.
ECLIA Series: 9 mins rapid test
As a leader in electrochemiluminescence immunoassay (ECLIA) technology in China, Lifotronic has introduced the fully automated eCL8000 and eCL9000 ECLIA analyzers, along with corresponding reagents, to meet the diverse testing needs of various customers. The large, high-speed eCL9000 analyzer delivers STAT test results in just 9 minutes, leveraging cutting-edge technology to ensure swift and accurate diagnostic outcomes. Achieving a single-module testing speed of 300 T/H and a maximum of 1200 T/H, it optimizes laboratory workflow while maintaining exceptional performance and reliability.
Advanced Hematology Analysis System
With its exceptional R&D capabilities,Wheisman, a wholly-owned subsidiary of Lifotronic, has successfully launched a series of hematology analyzers: AC310, AC610, and AC630. The AC630 five-part hematology analyzer stands out with its comprehensive 31 parameters and an impressive testing speed of 70 tests per hour. Designed to meet the demanding needs of modern laboratories, the AC630 enhances diagnostic accuracy and operational efficiency. Its advanced capabilities empower healthcare professionals with rapid and thorough blood analysis, supporting timely clinical decisions and patient care.
POCT: Portable Diagnostic Solution
Lifotronic's POCT solutions, exemplified by the FA-160 portable immunofluorescence analyzer, continue to revolutionize on-site diagnostics. Its portability and user-friendly design make it an invaluable tool for point-of-care testing, ensuring timely and accurate results that support immediate clinical decision-making.
These innovations from Lifotronic at Medalb Asia 2024 underscore their dedication to advancing healthcare diagnostics through cutting-edge technology. As we continue to unveil the latest developments, stay tuned for more updates on how Lifotronic is shaping the future of healthcare worldwide.
